Browse verified doctors or let our care team help you find the doctor best suited to your condition, treatment goals, and budget.
Delhi, India
Fortis Flt. Lt. Rajan Dhall Hospital is a trusted healthcare provider for Transarterial Radioembolization- TARE, offering advanced interventional oncology services supported by experienced specialists and modern medical infrastructure. Established in 2006, the NABH hospital is situated in Delhi, India and has 162 beds.
Transarterial Radioembolization (TARE) is a targeted treatment that delivers radiation directly to tumors in the liver through the hepatic arterial blood supply. It may be used when surgery or other treatments are not suitable or as part of a broader treatment strategy, depending on the patient's condition. Before the procedure, specialists assess the tumor and liver using imaging and other diagnostic tests. Regular follow-up helps evaluate tumor response and liver function.
Manipal Hospital, Hebbal is a trusted healthcare provider for Transarterial Radioembolization- TARE, offering advanced interventional oncology services supported by experienced specialists and modern medical infrastructure. Established in 1991, the NABL, NABH hospital is situated in Bangalore, India and has 280 beds.
Transarterial Radioembolization (TARE) is a targeted treatment that delivers radiation directly to tumors in the liver through the hepatic arterial blood supply. It may be used when surgery or other treatments are not suitable or as part of a broader treatment strategy, depending on the patient's condition. Before the procedure, specialists assess the tumor and liver using imaging and other diagnostic tests. Regular follow-up helps evaluate tumor response and liver function.
Max Super Speciality Hospital, Saket offers advanced Transarterial Radioembolization (TARE) using modern interventional radiology techniques and internationally accepted treatment protocols. Established in 2006, the JCI, NABH hospital is located in Delhi, India and has 539 beds, providing comprehensive care for local and international patients.
Transarterial Radioembolization (TARE) is a minimally invasive treatment primarily used for certain liver cancers and tumors that have spread to the liver. During the procedure, tiny radioactive microspheres are delivered through the hepatic artery to the tumor, where they release radiation locally while limiting exposure to surrounding healthy liver tissue. Before treatment, doctors generally perform imaging and other assessments to determine whether TARE is appropriate. Follow-up imaging helps evaluate the treatment response.
At Bayindir Healthcare Group, Transarterial Radioembolization- TARE is performed using advanced image-guided techniques and personalised treatment plans based on the patient's condition. Established in 1992, this JCI hospital in Ankara, Turkey has 153 beds and provides comprehensive cancer care.
Transarterial Radioembolization (TARE) may be considered for patients with selected liver tumors, including hepatocellular carcinoma and certain metastatic cancers. The procedure involves guiding a catheter through the blood vessels to the liver and delivering radioactive microspheres directly into the arteries supplying the tumor. Patients usually undergo imaging and laboratory assessments before treatment to evaluate liver function and vascular anatomy. Follow-up care and imaging are used to monitor response and manage potential side effects.
Gurgaon, India
Fortis Memorial Research Institute is a trusted healthcare provider for Transarterial Radioembolization- TARE, offering advanced interventional oncology services supported by experienced specialists and modern medical infrastructure. Established in 2013, the JCI, NABH, NABL hospital is situated in Gurgaon, India and has 311 beds.
Transarterial Radioembolization (TARE) is a targeted treatment that delivers radiation directly to tumors in the liver through the hepatic arterial blood supply. It may be used when surgery or other treatments are not suitable or as part of a broader treatment strategy, depending on the patient's condition. Before the procedure, specialists assess the tumor and liver using imaging and other diagnostic tests. Regular follow-up helps evaluate tumor response and liver function.
Acibadem University Hospital Atakent is a trusted healthcare provider for Transarterial Radioembolization- TARE, offering advanced interventional oncology services supported by experienced specialists and modern medical infrastructure. Established in 2014, the JCI hospital is situated in Istanbul, Turkey and has 278 beds.
Transarterial Radioembolization (TARE) is a targeted treatment that delivers radiation directly to tumors in the liver through the hepatic arterial blood supply. It may be used when surgery or other treatments are not suitable or as part of a broader treatment strategy, depending on the patient's condition. Before the procedure, specialists assess the tumor and liver using imaging and other diagnostic tests. Regular follow-up helps evaluate tumor response and liver function.
Istinye University Bahcesehir - LIV Hospital is a trusted healthcare provider for Transarterial Radioembolization- TARE, offering advanced interventional oncology services supported by experienced specialists and modern medical infrastructure. Established in 2016, the ISO, JCI hospital is situated in Istanbul, Turkey and has 394 beds.
Transarterial Radioembolization (TARE) is a targeted treatment that delivers radiation directly to tumors in the liver through the hepatic arterial blood supply. It may be used when surgery or other treatments are not suitable or as part of a broader treatment strategy, depending on the patient's condition. Before the procedure, specialists assess the tumor and liver using imaging and other diagnostic tests. Regular follow-up helps evaluate tumor response and liver function.
KCM Clinic is a trusted healthcare provider for Transarterial Radioembolization- TARE, offering advanced interventional oncology services supported by experienced specialists and modern medical infrastructure. Established in 2006, the ISO hospital is situated in Jelenia Gora, Poland and has 85 beds.
Transarterial Radioembolization (TARE) is a targeted treatment that delivers radiation directly to tumors in the liver through the hepatic arterial blood supply. It may be used when surgery or other treatments are not suitable or as part of a broader treatment strategy, depending on the patient's condition. Before the procedure, specialists assess the tumor and liver using imaging and other diagnostic tests. Regular follow-up helps evaluate tumor response and liver function.
Asian Institute of Medical Sciences is a trusted healthcare provider for Transarterial Radioembolization- TARE, offering advanced interventional oncology services supported by experienced specialists and modern medical infrastructure. Established in 2010, the NABL, NABH hospital is situated in Faridabad, India and has 425 beds.
Transarterial Radioembolization (TARE) is a targeted treatment that delivers radiation directly to tumors in the liver through the hepatic arterial blood supply. It may be used when surgery or other treatments are not suitable or as part of a broader treatment strategy, depending on the patient's condition. Before the procedure, specialists assess the tumor and liver using imaging and other diagnostic tests. Regular follow-up helps evaluate tumor response and liver function.
Apollo Hospital International Limited provides specialised Transarterial Radioembolization- TARE with a focus on precision, patient safety, and individualised cancer treatment. Established in 2003, the NABH, JCI hospital is located in Ahmedabad, India, and operates 300 beds, equipped with modern healthcare infrastructure.
Transarterial Radioembolization (TARE) is a form of locoregional radiation therapy designed to target tumors within the liver while reducing radiation exposure to healthy tissue. It is commonly used for selected primary liver cancers and metastatic tumors involving the liver. The treatment typically involves catheter-based delivery of radioactive microspheres into the tumor's arterial blood supply. Comprehensive evaluation before treatment and follow-up imaging afterwards help doctors assess suitability, treatment response, and liver health.
At Manipal Hospital, Gurugram, Transarterial Radioembolization- TARE is performed using advanced image-guided techniques and personalised treatment plans based on the patient's condition. Established in 2008, this NABL, NABH hospital in Gurgaon, India has 380 beds and provides comprehensive cancer care.
Transarterial Radioembolization (TARE) may be considered for patients with selected liver tumors, including hepatocellular carcinoma and certain metastatic cancers. The procedure involves guiding a catheter through the blood vessels to the liver and delivering radioactive microspheres directly into the arteries supplying the tumor. Patients usually undergo imaging and laboratory assessments before treatment to evaluate liver function and vascular anatomy. Follow-up care and imaging are used to monitor response and manage potential side effects.
Manipal Hospitals Goa, Dona Paula offers advanced Transarterial Radioembolization (TARE) using modern interventional radiology techniques and internationally accepted treatment protocols. Established in 1994, the NABH hospital is located in Panjim, India and has 235 beds, providing comprehensive care for local and international patients.
Transarterial Radioembolization (TARE) is a minimally invasive treatment primarily used for certain liver cancers and tumors that have spread to the liver. During the procedure, tiny radioactive microspheres are delivered through the hepatic artery to the tumor, where they release radiation locally while limiting exposure to surrounding healthy liver tissue. Before treatment, doctors generally perform imaging and other assessments to determine whether TARE is appropriate. Follow-up imaging helps evaluate the treatment response.
Acibadem Altunizade Hospital is a trusted healthcare provider for Transarterial Radioembolization- TARE, offering advanced interventional oncology services supported by experienced specialists and modern medical infrastructure. Established in 2017, the JCI, ISO hospital is situated in Istanbul, Turkey and has 350 beds.
Transarterial Radioembolization (TARE) is a targeted treatment that delivers radiation directly to tumors in the liver through the hepatic arterial blood supply. It may be used when surgery or other treatments are not suitable or as part of a broader treatment strategy, depending on the patient's condition. Before the procedure, specialists assess the tumor and liver using imaging and other diagnostic tests. Regular follow-up helps evaluate tumor response and liver function.
Sheba Medical Center offers advanced Transarterial Radioembolization (TARE) using modern interventional radiology techniques and internationally accepted treatment protocols. Established in 1948, the JCI hospital is located in Ramat Gan, Israel and has 1900 beds, providing comprehensive care for local and international patients.
Transarterial Radioembolization (TARE) is a minimally invasive treatment primarily used for certain liver cancers and tumors that have spread to the liver. During the procedure, tiny radioactive microspheres are delivered through the hepatic artery to the tumor, where they release radiation locally while limiting exposure to surrounding healthy liver tissue. Before treatment, doctors generally perform imaging and other assessments to determine whether TARE is appropriate. Follow-up imaging helps evaluate the treatment response.
Herzliya Medical Center is a trusted healthcare provider for Transarterial Radioembolization- TARE, offering advanced interventional oncology services supported by experienced specialists and modern medical infrastructure. Established in 1983, the hospital is situated in Herzliya, Israel and has 120 beds.
Transarterial Radioembolization (TARE) is a targeted treatment that delivers radiation directly to tumors in the liver through the hepatic arterial blood supply. It may be used when surgery or other treatments are not suitable or as part of a broader treatment strategy, depending on the patient's condition. Before the procedure, specialists assess the tumor and liver using imaging and other diagnostic tests. Regular follow-up helps evaluate tumor response and liver function.